|
1
|
Konieczkowski DJ, Johannessen CM and
Garraway LA: A convergence-based framework for cancer drug
resistance. Cancer Cell. 33:801–815. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
An X, Sarmiento C, Tan T and Zhu H:
Regulation of multidrug resistance by microRNAs in anti-cancer
therapy. Acta Pharm Sin B. 7:38–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan ST, Li ZL, He ZX, Qiu JX and Zhou SF:
Molecular mechanisms for tumour resistance to chemotherapy. Clin
Exp Pharmacol Physiol. 43:723–737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tooze SA and Dikic I: Autophagy captures
the nobel prize. Cell. 167:1433–1435. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kimmelman AC and White E: Autophagy and
tumor metabolism. Cell Metab. 25:1037–1043. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu L, Chen Y and Tooze SA: Autophagy
pathway: Cellular and molecular mechanisms. Autophagy. 14:207–215.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hurley JH and Young LN: Mechanisms of
autophagy initiation. Annu Rev Biochem. 86:225–244. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang
C, Wang F, Zhang CY, Zen K and Li L: miR-26 enhances
chemosensitivity and promotes apoptosis of hepatocellular carcinoma
cells through inhibiting autophagy. Cell Death Dis. 8:e25402017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rothschild SI, Gautschi O, Batliner J,
Gugger M, Fey MF and Tschan MP: MicroRNA-106a targets autophagy and
enhances sensitivity of lung cancer cells to Src inhibitors. Lung
Cancer. 107:73–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie
T, Zhang J, Peng C, Lin Y and Chen J: MicroRNA-25 regulates
chemoresistance-associated autophagy in breast cancer cells, a
process modulated by the natural autophagy inducer
isoliquiritigenin. Oncotarget. 5:7013–7026. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hara T, Takamura A, Kishi C, Iemura S,
Natsume T, Guan JL and Mizushima N: FIP200, a ULK-interacting
protein, is required for autophagosome formation in mammalian
cells. J Cell Biol. 181:497–510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng Y, Ban R, Liu W, Wang H, Li S, Yue
Z, Zhu G, Zhuan Y and Wang C: miRNA-409-3p enhances
cisplatin-sensitivity of ovarian cancer cells by blocking the
autophagy mediated by Fip200. Oncol Res. Jan 2–2018.(Epub ahead of
print). View Article : Google Scholar
|
|
18
|
Lu D, Yang C, Zhang Z, Cong Y and Xiao M:
Knockdown of Linc00515 inhibits multiple myeloma autophagy and
chemoresistance by upregulating miR-140-5p and downregulating
ATG14. Cell Physiol Biochem. 48:2517–2527. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marchese FP, Raimondi I and Huarte M: The
multidimensional mechanisms of long noncoding RNA function. Genome
Biol. 18:2062017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoon JH, Abdelmohsen K and Gorospe M:
Functional interactions among microRNAs and long noncoding RNAs.
Semin Cell Dev Biol. 34:9–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu
LZ and Jiang BH: Downregulation of ATG14 by EGR1-MIR152 sensitizes
ovarian cancer cells to cisplatin-induced apoptosis by inhibiting
cyto-protective autophagy. Autophagy. 11:373–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu R, Liu S, Chen H and Lao L:
MicroRNA-30a downregulation contributes to chemoresistance of
osteosarcoma cells through activating Beclin-1-mediated autophagy.
Oncol Rep. 35:1757–1763. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng B, Zhu H, Gu D, Pan X, Qian L, Xue
B, Yang D, Zhou J and Shan Y: MiRNA-30a-mediated autophagy
inhibition sensitizes renal cell carcinoma cells to sorafenib.
Biochem Biophys Res Commun. 459:234–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L,
Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, et al: Regulation of
autophagy by miR-30d impacts sensitivity of anaplastic thyroid
carcinoma to cisplatin. Biochem Pharmacol. 87:562–570. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo M, Wu L, Zhang K, Wang H, Wu S,
O'Connell D, Gao T, Zhong H and Yang Y: miR-216b enhances the
efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in
melanoma. Cell Signal. 42:30–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan S, Shi H, Ba M, Lin S, Tang H, Zeng X
and Zhang X: miR-409-3p sensitizes colon cancer cells to
oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Mol
Med. 37:1030–1038. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen K and Shi W: Autophagy regulates
resistance of non-small cell lung cancer cells to paclitaxel.
Tumour Biol. 37:10539–10544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R,
Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in
osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Zhou X, Qiao J and Bao A:
MiR-142-3p overexpression increases chemo-sensitivity of NSCLC by
inhibiting HMGB1-mediated autophagy. Cell Physiol Biochem.
41:1370–1382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiong J, Wang D, Wei A, Ke N, Wang Y, Tang
J, He S, Hu W and Liu X: MicroRNA-410-3p attenuates gemcitabine
resistance in pancreatic ductal adenocarcinoma by inhibiting
HMGB1-mediated autophagy. Oncotarget. 8:107500–107512. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ran X, Yang J, Liu C, Zhou P, Xiao L and
Zhang K: miR-218 inhibits HMGB1-mediated autophagy in endometrial
carcinoma cells during chemotherapy. Int J Clin Exp Pathol.
8:6617–6626. 2015.PubMed/NCBI
|
|
32
|
Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang
Y, Wang Y, Zhao W and Wang W: miR-22 inhibits osteosarcoma cell
proliferation and migration by targeting HMGB1 and inhibiting
HMGB1-mediated autophagy. Tumour Biol. 35:7025–7034. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu K, Huang J, Xie M, Yu Y, Zhu S, Kang
R, Cao L, Tang D and Duan X: MIR34A regulates autophagy and
apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy.
10:442–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim YC and Guan KL: mTOR: A pharmacologic
target for autophagy regulation. J Clin Invest. 125:25–32. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han J, Li J, Tang K, Zhang H, Guo B, Hou N
and Huang C: miR-338-3p confers 5-fluorouracil resistance in p53
mutant colon cancer cells by targeting the mammalian target of
rapamycin. Exp Cell Res. 360:328–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang C, Shen F, Du J, Fang X, Li X, Su J,
Wang X, Huang X and Liu Z: Upregulation of CASC2 sensitized glioma
to temozolomide cytotoxicity through autophagy inhibition by
sponging miR-193a-5p and regulating mTOR expression. Biomed
Pharmacother. 97:844–850. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hildebrandt MA, Yang H, Hung MC, Izzo JG,
Huang M, Lin J, Ajani JA and Wu X: Genetic variations in the
PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in
esophageal cancer patients treated with chemoradiotherapy. J Clin
Oncol. 27:857–871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lim HJ, Crowe P and Yang JL: Current
clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment
of human cancer. J Cancer Res Clin Oncol. 141:671–689. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang L, Tang B, Han H, Mao D, Chen J, Zeng
Y and Xiong M: miR-155 affects osteosarcoma MG-63 cell autophagy
induced by adriamycin through regulating PTEN-PI3K/AKT/mTOR
signaling pathway. Cancer Biother Radiopharm. 33:32–38. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu X, Li R, Shi W, Jiang T, Wang Y, Li C
and Qu X: Silencing of MicroRNA-21 confers the sensitivity to
tamoxifen and fulvestrant by enhancing autophagic cell death
through inhibition of the PI3K-AKT-mTOR pathway in breast cancer
cells. Biomed Pharmacother. 77:37–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He C, Dong X, Zhai B, Jiang X, Dong D, Li
B, Jiang H, Xu S and Sun X: MiR-21 mediates sorafenib resistance of
hepatocellular carcinoma cells by inhibiting autophagy via the
PTEN/Akt pathway. Oncotarget. 6:28867–28881. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mizushima N: Autophagy: Process and
function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kirkin V, McEwan DG, Novak I and Dikic I:
A role for ubiquitin in selective autophagy. Mol Cell. 34:259–269.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
YiRen H, YingCong Y, Sunwu Y, Keqin L,
Xiaochun T, Senrui C, Ende C, XiZhou L and Yanfan C: Long noncoding
RNA MALAT1 regulates autophagy associated chemoresistance via
miR-23b-3p sequestration in gastric cancer. Mol Cancer. 16:1742017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen R, Li X, He B and Hu W: MicroRNA-410
regulates autophagy-related gene ATG16L1 expression and enhances
chemosensitivity via autophagy inhibition in osteosarcoma. Mol Med
Rep. 15:1326–1334. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao J, Nie Y, Wang H and Lin Y: MiR-181a
suppresses autophagy and sensitizes gastric cancer cells to
cisplatin. Gene. 576:828–833. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang K, Chen J, Zhou H, Chen Y, Zhi Y,
Zhang B, Chen L, Chu X, Wang R and Zhang C: PU.1/microRNA-142-3p
targets ATG5/ATG16L1 to inactivate autophagy and sensitize
hepatocellular carcinoma cells to sorafenib. Cell Death Dis.
9:3122018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
An Y, Zhang Z, Shang Y, Jiang X, Dong J,
Yu P, Nie Y and Zhao Q: miR-23b-3p regulates the chemoresistance of
gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis.
6:e17662015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z, Liu
L, Kang X and Chen Y: Methylation-induced silencing of miR-34a
enhances chemoresistance by directly upregulating ATG4B-induced
autophagy through AMPK/mTOR pathway in prostate cancer. Oncol Rep.
35:64–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wu Y, Ni Z, Yan X, Dai X, Hu C, Zheng Y,
He F and Lian J: Targeting the MIR34C-5p-ATG4B-autophagy axis
enhances the sensitivity of cervical cancer cells to pirarubicin.
Autophagy. 12:1105–1117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu L, Shen W, Zhu Z, Lin J, Fang Q, Ruan
Y and Zhao H: Combined inhibition of EGFR and c-ABL suppresses the
growth of fulvestrant-resistant breast cancer cells through
miR-375-autophagy axis. Biochem Biophys Res Commun. 498:559–565.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gao AM, Zhang XY, Hu JN and Ke ZP:
Apigenin sensitizes hepatocellular carcinoma cells to doxorubic
through regulating miR-520b/ATG7 axis. Chem Biol Interact.
280:45–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sun W, Zu Y, Fu X and Deng Y: Knockdown of
lncRNA-XIST enhances the chemosensitivity of NSCLC cells via
suppression of autophagy. Oncol Rep. 38:3347–3354. 2017.PubMed/NCBI
|
|
54
|
Stiuso P, Potenza N, Lombardi A,
Ferrandino I, Monaco A, Zappavigna S, Vanacore D, Mosca N,
Castiello F, Porto S, et al: MicroRNA-423-5p promotes autophagy in
cancer cells and is increased in serum from hepatocarcinoma
patients treated with sorafenib. Mol Ther Nucleic Acids.
4:e2332015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Comincini S, Allavena G, Palumbo S, Morini
M, Durando F, Angeletti F, Pirtoli L and Miracco C: MicroRNA-17
regulates the expression of ATG7 and modulates the autophagy
process, improving the sensitivity to temozolomide and low-dose
ionizing radiation treatments in human glioblastoma cells. Cancer
Biol Ther. 14:574–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F
and Xia Q: Cisplatin-induced downregulation of miR-199a-5p
increases drug resistance by activating autophagy in HCC cell.
Biochem Biophys Res Commun. 423:826–831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li Y, Iglehart JD, Richardson AL and Wang
ZC: The amplified cancer gene LAPTM4B promotes tumor growth and
tolerance to stress through the induction of autophagy. Autophagy.
8:273–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Blom T, Li S, Dichlberger A, Bäck N, Kim
YA, Loizides-Mangold U, Riezman H, Bittman R and Ikonen E: LAPTM4B
facilitates late endosomal ceramide export to control cell death
pathways. Nat Chem Biol. 11:799–806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Soni M, Patel Y, Markoutsa E, Jie C, Liu
S, Xu P and Chen H: Autophagy, cell viability, and chemoresistance
are regulated by miR-489 in breast cancer. Mol Cancer Res.
16:1348–1360. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Eskelinen EL: Roles of LAMP-1 and LAMP-2
in lysosome biogenesis and autophagy. Mol Aspects Med. 27:495–502.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Bao L, Lv L, Feng J, Chen Y, Wang X, Han S
and Zhao H: miR-487b-5p regulates temozolomide resistance of lung
cancer cells through LAMP2-medicated autophagy. DNA Cell Biol.
35:385–392. 2016. View Article : Google Scholar : PubMed/NCBI
|
